Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16265844 | 0.92 | — | — | |
| SCHEMBL16265788 | 0.92 | ALDH1A1 (0.35) | ALDH1A1CYP2D6 | |
| SCHEMBL16265656 | 0.89 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL16265724 | 0.88 | CYP3A4 (0.39) | ALDH1A1 | |
| SCHEMBL16265440 | 0.84 | CYP3A4 (0.30) | — | |
| SCHEMBL16265562 | 0.83 | ALDH1A1 (0.35) | ALDH1A1CYP2D6 | |
| SCHEMBL16265766 | 0.82 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL16265708 | 0.81 | CYP3A4 (0.38) | ALDH1A1 | |
| SCHEMBL16265734 | 0.81 | ALDH1A1 (0.36) | ALDH1A1CYP2D6 | |
| SCHEMBL16265580 | 0.80 | CYP3A4 (0.38) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2808329-B1 | Silyl-Protected Nitrogen-Containing Cyclic Compounds and their method of preparation | SHINETSU CHEMICAL CO (JP) | 2018-09-26 | — | — | EP | disclosed |
| US-9233988-B2 | Silyl-protected nitrogen-containing cyclic compounds and making method | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-01-12 | — | — | US | disclosed |
| US-20140357862-A1 | SILYL-PROTECTED NITROGEN-CONTAINING CYCLIC COMPOUNDS AND MAKING METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-12-04 | — | — | US | disclosed |
| EP-2808329-A1 | Silyl-Protected Nitrogen-Containing Cyclic Compounds and Making Method | Shin-Etsu Chemical Co., Ltd. (JP) | 2014-12-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357862-A1 | SILYL-PROTECTED NITROGEN-CONTAINING CYCLIC COMPOUNDS AND MAKING METHOD | PRMT9, CCNO, IPO9 | ALDH1A1 3666/4885CYP2D6 4195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.